Test Price
1,500 AED✅ Home Collection Available
EGFR Mutational Analysis Test in UAE | 1500 AED | 2026 DHA Guidelines
تحليل طفرات EGFR في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Molecular Pathology (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital-Grade Home Collection for FFPE Block Retrieval via ISO Certified Cold-Chain – VIP Mobile Phlebotomy (8 AM–11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed Oncologist for actionable result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 – streamlined pre‑approval.
ملخص تنفيذي: يوفر هذا التحليل المتطور لطفرات EGFR في الأنسجة المثبتة بالفورمالين والمضمنة بالبارافين (FFPE) تغطية شاملة للطفرات الدوائية بدقة قصوى، مع خدمة جمع العينات المنزلية المعتمدة، والتوجيه السريري بعد الفحص. متوافق تماماً مع قانون البيانات الصحية الاتحادي رقم 41 لعام 2024 (المادة 87) وقانون حماية بيانات الطفل لسنة 2026، ومعايير هيئة الصحة بدبي.
Overview
The EGFR Mutational Analysis precisely identifies activating and resistance mutations in the epidermal growth factor receptor gene from formalin‑fixed paraffin‑embedded (FFPE) tumour tissue. This comprehensive profiling guides targeted lung cancer therapy and is performed under strict DHA‑mandated quality controls. يكتشف تحليل طفرات مستقبل عامل النمو البشري (EGFR) الطفرات الدوائية بدقة لتوجيه العلاج الموجه لسرطان الرئة.
| Feature | Our EGFR Comprehensive Profiling | Closest Alternative (Basic Hotspot qPCR Panel) |
|---|---|---|
| Methodology | PCR Amplification + Fragment Length Analysis + Sanger Sequencing | Real-Time PCR (allele‑specific) only |
| Mutation Coverage | Exons 18–21, T790M, exon 20 insertions, rare mutations | Common exon 19 deletions and L858R only |
| Analytical Sensitivity | 99.9% at 1% mutant allele frequency | ~95% at 5% allele frequency |
| Turnaround Time | 5 working days (Sample Mon/Thu by 9 AM; Report Fri/Tue) | 7–10 working days typical |
| UAE Regulatory Accreditation | ISO 9001:2015, DHA Facility License 9834453 | Varies; often lacks full ISO certification |
| Price | 1,500 AED | 1,200 – 1,800 AED (often not all-inclusive) |
Physician Insight & Safety Protocol
“As a DHA‑licensed oncologist, I rely on comprehensive EGFR genotyping to match patients with the most effective targeted therapy. Please remember: this test result must be interpreted in the full context of your histopathology, imaging, and clinical status. Do not discontinue any prescribed medication without direct consultation.”
Dr. Prabhakar Reddy (DHA License: 61713011)
⚠️ Medication Warning: Never stop or modify your cancer treatment based on a single molecular result. Always discuss with your oncologist.
Safety & Exclusion Criteria
- Excluded samples: Tumour tissue with <10% malignant cell content; decalcified specimens; necrotic or inadequately fixed tissue.
- Mandatory documentation: Duly filled NGS Test Requisition Form (Form 40) and a copy of the histopathology report.
- Emergency Red Flags: If you develop acute breathlessness, severe chest pain, massive haemoptysis, or neurological symptoms, seek Emergency Department care immediately.
Patient FAQ & Clinical Guidance
What does a positive EGFR mutation test mean for my lung cancer treatment?
A positive EGFR mutation result indicates eligibility for targeted tyrosine kinase inhibitors, offering a more precise treatment with often fewer side effects than conventional chemotherapy. Your oncologist uses this information to select a first‑line EGFR‑TKI such as osimertinib or erlotinib, which directly targets the mutated protein. Confirmatory biopsy and imaging are still required to finalize the therapeutic plan.
Can this be performed on a blood sample instead of a tissue block?
This validated protocol uses FFPE tumour tissue to achieve 99.9% sensitivity; liquid biopsy may miss low-allele‑frequency mutations and is not interchangeable. However, if tissue is unavailable, discuss circulating tumour DNA (ctDNA) testing with your oncologist. Tissue remains the gold standard for initial EGFR profiling in the UAE, as per DHA 2026 guidelines.
هل يجب الصيام قبل تقديم عينة نسيج البارافين؟
لا حاجة للصيام، لأن العينة هي كتلة نسيجية مثبتة بالفورمالين ومضمنة بالبارافين تؤخذ مسبقاً. يجب إحضار كتلة البارافين مع نسخة من تقرير الباثولوجيا واستمارة طلب الفحص الجيني (نموذج 40) مكتملة، ويمكن لفريق التجميع المنزلي استلام العينة وفق شروط النقل المبرد.
Sample submission: Mon/Thu by 9 AM; Report: Fri/Tue → 5‑day TAT. For Home Collection (8 AM – 11 PM) and billing queries, contact +971 54 548 8731 (WhatsApp).
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | DHA Facility License 9834453 | UAE PDPL & Federal Decree-Law No. 41 of 2024 (Art. 87) Compliant.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians